Synexus Czech s.r.o.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Type 2 diabetes1 trial

Phase

• Phase 32 trials

Status

• Recruiting2 trials

Lead sponsor

• Ascletis Pharma (China) Co. Ltd.2 trials

Running trials

• Recruiting

  Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Weight-Related Comorbidities

  2026-526172-23-00· Phase 3· Ascletis Pharma (China) Co. Ltd.· Source

• Recruiting

  Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus

  2026-526336-39-00· Phase 3· Ascletis Pharma (China) Co. Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Type 2 diabetes1 recruiting